AstraZeneca EBITDA 2010-2024 | AZN

AstraZeneca EBITDA for the quarter ending September 30, 2024 was $3.923B, a 21.23% increase year-over-year.

  • AstraZeneca 2023 EBITDA was 13.58B, a 47.02% increase from 2022.
  • AstraZeneca 2022 EBITDA was 9.237B, a 21.76% increase from 2021.
  • AstraZeneca 2021 EBITDA was 7.586B, a 8.72% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

AstraZeneca EBITDA 2010-2024 | AZN

  • AstraZeneca 2023 EBITDA was 13.58B, a 47.02% increase from 2022.
  • AstraZeneca 2022 EBITDA was 9.237B, a 21.76% increase from 2021.
  • AstraZeneca 2021 EBITDA was 7.586B, a 8.72% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B